UNICA IRIS Institutional Research Information System

FLORIS, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 92.364
NA - Nord America 4.570
AS - Asia 2.362
Continente sconosciuto - Info sul continente non disponibili 387
SA - Sud America 331
AF - Africa 60
OC - Oceania 5
Totale 100.079
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 91.394
US - Stati Uniti d'America 4.455
SG - Singapore 956
CN - Cina 666
VN - Vietnam 250
BR - Brasile 247
SE - Svezia 216
DE - Germania 171
FI - Finlandia 124
FR - Francia 104
UA - Ucraina 95
GB - Regno Unito 89
HK - Hong Kong 88
CA - Canada 70
IN - India 70
BD - Bangladesh 67
NL - Olanda 42
JP - Giappone 41
IQ - Iraq 37
AR - Argentina 30
ES - Italia 30
KR - Corea 30
ZA - Sudafrica 21
MX - Messico 19
PL - Polonia 17
PK - Pakistan 16
ID - Indonesia 15
CO - Colombia 14
IR - Iran 14
RU - Federazione Russa 12
AT - Austria 11
CL - Cile 11
UZ - Uzbekistan 11
EC - Ecuador 10
EG - Egitto 10
IE - Irlanda 10
MA - Marocco 10
CZ - Repubblica Ceca 9
IL - Israele 9
MY - Malesia 9
SA - Arabia Saudita 9
TR - Turchia 9
GR - Grecia 8
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
JO - Giordania 7
PH - Filippine 7
BE - Belgio 6
PS - Palestinian Territory 6
AU - Australia 5
KE - Kenya 5
LT - Lituania 5
TW - Taiwan 5
UY - Uruguay 5
VE - Venezuela 5
AL - Albania 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
LV - Lettonia 2
MM - Myanmar 2
OM - Oman 2
PT - Portogallo 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
Totale 99.688
Salva come PNG Salva come JPEG
Città #
Cagliari 88.586
Uta 2.433
Dallas 552
Singapore 551
Ashburn 469
Fairfield 286
San Jose 267
Boardman 208
Woodbridge 177
Houston 174
Chandler 154
Beijing 137
Los Angeles 123
Wilmington 121
Nyköping 116
Ann Arbor 113
Council Bluffs 113
Cambridge 107
Seattle 98
Helsinki 93
Shanghai 88
Santa Clara 87
New York 85
Hong Kong 78
The Dalles 70
Ho Chi Minh City 65
Lauterbourg 61
Dong Ket 58
Dearborn 52
Munich 51
Hefei 50
Boston 46
Jacksonville 45
Buffalo 44
Rome 43
Chicago 38
Milan 37
Hanoi 34
Seoul 29
Orem 27
Tokyo 25
Redwood City 24
São Paulo 24
London 23
Nanjing 22
Amsterdam 21
Toronto 21
Frankfurt am Main 20
Phoenix 20
San Diego 20
Baghdad 19
Guangzhou 19
Montreal 19
Denver 18
Brooklyn 16
Nuremberg 16
Warsaw 15
Atlanta 12
Da Nang 12
Lappeenranta 12
Redondo Beach 12
Madrid 11
Mumbai 11
Nanchang 11
Salt Lake City 11
Tashkent 11
Chennai 10
Haiphong 10
Johannesburg 10
Turku 10
Dhaka 9
Elk Grove Village 9
Hebei 9
Paris 9
San Francisco 9
Shenzhen 9
Belo Horizonte 8
Changsha 8
Mountain View 8
Stockholm 8
Vancouver 8
Buenos Aires 7
Dublin 7
Düsseldorf 7
Florence 7
Guayaquil 7
Hyderabad 7
North Bergen 7
Rio de Janeiro 7
Santiago 7
Tampa 7
Tianjin 7
Washington 7
Xi'an 7
Baku 6
Brussels 6
Erbil 6
Falls Church 6
Manchester 6
Mexico City 6
Totale 96.672
Salva come PNG Salva come JPEG
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.755
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.185
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.072
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.068
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 3.033
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.909
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.831
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.830
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.801
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.632
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.621
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.345
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.290
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.265
Polymyalgia rheumatica: an autoinflammatory disorder? 2.247
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.183
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.182
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.171
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.097
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.079
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 2.034
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.944
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice 1.800
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.703
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.659
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.641
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.584
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.496
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.367
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist 1.275
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.195
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.187
Targeted Therapies in Axial Psoriatic Arthritis 1.184
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.087
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 1.079
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.075
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.062
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.059
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.005
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 936
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 920
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 900
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 883
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis 882
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 865
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 859
Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study 850
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 822
Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity 808
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 782
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study 770
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 726
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 569
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 562
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 352
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review 336
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 245
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 185
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 102
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis 97
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 93
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 92
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 71
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 70
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 61
Risk of major organ involvement in Behçet's patients with mucocutaneous onset: Data from the AIDA Network Registry 32
The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry 29
The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study 28
The impact of demographics on organ damage in Behçet’s syndrome: a cross-sectional analysis of the international PROBE cohort 25
Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature review 20
VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries 20
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 16
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study 15
Phenotypic differences and treatment persistence in a large multicentre cohort of axial psoriatic arthritis 13
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 11
Totale 100.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.582 0 243 264 187 355 302 254 297 520 600 908 652
2022/20236.923 568 895 696 503 508 763 403 565 515 548 621 338
2023/202413.146 362 372 389 777 1.052 1.409 1.457 4.113 495 567 1.210 943
2024/202531.521 11.169 8.598 5.106 2.186 1.164 1.147 1.259 86 199 163 221 223
2025/20265.631 335 403 623 347 477 355 1.000 508 414 485 506 178
2026/2027392 388 4 0 0 0 0 0 0 0 0 0 0
Totale 100.079